GLP1R and liver dysplastic nodule: While a relatively small number of studies have demonstrated the effectiveness of GLP-1 therapy on human DN, intravenous infusion of GLP-1 in insulin-resistant states was shown to increase sodium excretion, reduce H+ secretion, and reduce glomerular hyperfiltration, leading to renoprotective effects [67].